Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Colorectal Neoplasms 21Anus Neoplasms 17Carcinoma, Hepatocellular 11Appendiceal Neoplasms 11Stomach Neoplasms 10Neoplasm Metastasis 9Peritoneal Neoplasms 8Pancreatic Neoplasms 8Colonic Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Anal Canal Carcinoma 4Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Uterine Neoplasms 2Pseudomyxoma Peritonei 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence Hepatocellular Carcinoma 1Recurrence 1Pleural Neoplasms 1Peritoneal Diseases 1Neoplasms, Squamous Cell 1Neoplasms 1Necrosis 1Mesothelioma 1Mediastinal Neoplasms 1Locally Advanced Anal Canal Cancer 1Hyperthermia 1HIV Infections 1

Interventions

Oxaliplatin 10Gemcitabine 8Cisplatin 7Hepatectomy 6Fluorouracil 6Radiofrequency Ablation 5Liver Transplantation 5Irinotecan 5Capecitabine 5lenvatinib 4Paclitaxel 4Neoadjuvant Therapy 4Folfox protocol 4Cetuximab 4Aspirin 4tislelizumab 3Surgical Procedures, Operative 3Nivolumab 3Carboplatin 3titanium silicide 2durvalumab 2apatinib 2Trastuzumab 2S 1 (combination) 2Leucovorin 2Lamivudine 2Introns 2Ethiodized Oil 2Drug Therapy 2DNA, Mitochondrial 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Mitomycin × Gastrointestinal × Clear all
NCT00644020 2008-03-26

Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡